Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore

NCT ID: NCT01177839

Last Updated: 2012-11-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

178 participants

Study Classification

OBSERVATIONAL

Study Start Date

2002-05-31

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective study aims to estimate the incidence of intussusception among children \< 2 years old through hospital-based surveillance in Singapore.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intussusception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intussusception cohort

Subjects with Intussusception

Screening sheets

Intervention Type OTHER

Reviewing screening sheets

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Screening sheets

Reviewing screening sheets

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A male or female infant aged \< 24months at the time of diagnosis of intussusception.
* Subject is diagnosed with definite, probable, possible, suspected intussusception during the period of at least one year beginning at study start.
* Written informed consent obtained from the parent or guardian of the subject.

Exclusion Criteria

* A male or female infant ≥ 24 months of age at the time of intussusception diagnosis.
* The subject has had a radiographically or surgically confirmed case of intussusception prior to the current episode.
Maximum Eligible Age

24 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GlaxoSmithKline

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GSK Clinical Trials

Role: STUDY_DIRECTOR

GlaxoSmithKline

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GSK Investigational Site

Singapore, , Singapore

Site Status

GSK Investigational Site

Singapore, , Singapore

Site Status

GSK Investigational Site

Singapore, , Singapore

Site Status

GSK Investigational Site

Singapore, , Singapore

Site Status

GSK Investigational Site

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

References

Explore related publications, articles, or registry entries linked to this study.

Phua KB, Lee BW, Quak SH, Jacobsen A, Teo H, Vadivelu-Pechai K, Gopala K, Liu Y. Incidence of intussusception in Singaporean children aged less than 2 years: a hospital-based prospective study. BMC Pediatr. 2013 Oct 8;13:161. doi: 10.1186/1471-2431-13-161.

Reference Type DERIVED
PMID: 24103115 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

999910/193

Identifier Type: -

Identifier Source: org_study_id